After reaching an important support level, Amphenol (APH) could be a good stock pick from a technical perspective. APH surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Amphenol Corporation (APH) Q4 2025 Earnings Call Transcript
Amphenol Corporation delivered strong Q4 results, but shares dropped on the news. While the APH numbers were great, the beat was modest as compared to prior quarters, perhaps leaving investors wanting more. Q1 guidance, while strong on a year-over-year basis, implies a sequential decline in EPS versus the most recent quarter.
Amphenol Corporation offers a compelling entry point after a sharp post-earnings sell-off, despite strong quarterly results and bullish guidance. APH's high valuation (P/E ~48) is justified by robust growth, strong margins, and ongoing AI-driven data center demand. Q4 revenue surged 50% YOY to $6.44B, with adjusted EPS up 76% and operating margins exceeding 26%.
APH posts 76% EPS growth and 49% sales surge in Q4, driven by IT datacom strength and acquisitions, yet shares dip 15%.
While the top- and bottom-line numbers for Amphenol (APH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amphenol (APH) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.55 per share a year ago.
APH sees up to 65% EPS growth in Q4 2025, driven by AI demand, acquisitions and strength in key end markets.
BWMX, LRCX and APH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 23, 2026.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Amphenol (APH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RGLD, NVDA, EXPE and APH hold promise.
Amphenol (APH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.